Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 03 Dec 2024

Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers

in Cancer Immunity and Immunotherapy

Qinlan Xu
Dong Shao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487610

821 views

Editorial

Published on 03 Dec 2024

Editorial: Investigating tumor immunotherapy responses in lung cancer using deep learning

in Cancer Immunity and Immunotherapy

Shuang Qin
Haoxiang Zhang
Chao Liu
Ming Yi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1529949

718 views

Review

Published on 03 Dec 2024

Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease

in Cancer Immunity and Immunotherapy

Sijia Yan
Xi Ming
Xiaojian Zhu
Yi Xiao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451977

1,056 views

Original Research

Published on 03 Dec 2024

Integrating omics data and machine learning techniques for precision detection of oral squamous cell carcinoma: evaluating single biomarkers

in Cancer Immunity and Immunotherapy

Yilan Sun
Guozhen Cheng
Dongliang Wei
Jiacheng Luo
Jiannan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493377

952 views

Correction

Published on 03 Dec 2024

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

in Cancer Immunity and Immunotherapy

Tongshan Wang
Muyang Chen
Anpeng Wang
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1530843

335 views

Correction

Published on 03 Dec 2024

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

in Cancer Immunity and Immunotherapy

Siyu Zhang
Changxin Huang
Yongqiang Li
Zhaoyang Li
Ying Zhu
Lili Yang
Haokun Hu
Quan Sun
Mengmeng Liu
Songqiang Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514836

454 views

Systematic Review

Published on 03 Dec 2024

Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis

in Cancer Immunity and Immunotherapy

Yuan Kang
Yixin Kang
Dianbao Zhang
Jun Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460533

772 views

Original Research

Published on 03 Dec 2024

A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy

in Cancer Immunity and Immunotherapy

Zhiyi Zhao
Hongling Jia
Zhou Sun
Yumeng Li
Lingyun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485109

978 views

Original Research

Published on 03 Dec 2024

Identification of SPP1+ macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics

in Cancer Immunity and Immunotherapy

Han Jin
Woonghee Kim
Meng Yuan
Xiangyu Li
Hong Yang
Mengzhen Li
Mengnan Shi
Hasan Turkez
Mathias Uhlen
Cheng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446453

2,523 views

Original Research

Published on 02 Dec 2024

Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor Immune Microenvironment) in distant tumors

in Cancer Immunity and Immunotherapy

Flávia Sardela de Miranda
Dalia Martinez-Marin
Rachel L. Babcock
Maribel Castro
Geetha P. Boligala
Sonia Y. Khan
Kathryn L. Furr
Isabel Castro-Piedras
Nicholas Wagner
Dakota E. Robison

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498942

2,063 views

Original Research

Published on 02 Dec 2024

Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma

in Cancer Immunity and Immunotherapy

Jing Ruan
Daobin Zhou
Yan Zhang
Danqing Zhao
Chong Wei
Ke Hu
Fuquan Zhang
Xiaorong Hou
Wei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481080

1,241 views

Original Research

Published on 02 Dec 2024

Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma

in Cancer Immunity and Immunotherapy

Saima Jamil Farooqi
Zhi Zhao
Åsa Kristina Öjlert
Solfrid Thunold
Hedvig Vidarsdotter Juul
Maria Moksnes Bjaanæs
Henrik Horndalsveen
Hanne Marte Gjertsen Nymoen
Åslaug Helland
Vilde Drageset Haakensen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480183

1,627 views

Clinical Trial

Published on 02 Dec 2024

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study

in Cancer Immunity and Immunotherapy

Na Zhou
Yuwei Hua
Yuping Ge
Qiang Wang
Chenyu Wang
Jia He
Luo Zhao
Shuangni Yu
Junfang Yan
Lin Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482005

1,247 views

Case Report

Published on 02 Dec 2024

Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports

in Cancer Immunity and Immunotherapy

Kevin Y. Li
Andrew M. Lowy
Paul Fanta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452543

803 views
1 citation

Original Research

Published on 02 Dec 2024

Research on the influence of radiotherapy-related genes on immune infiltration, immunotherapy response and prognosis in melanoma based on multi-omics

in Cancer Immunity and Immunotherapy

Yujing Shi
Wantong Zhao
Yuanjian Ding
Xiaolin Ge
Mengyang Ju

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467098

1,387 views

Editorial

Published on 02 Dec 2024

Editorial: Immune cell exhaustion: new challenges and opportunities in cancer therapy

in Cancer Immunity and Immunotherapy

Hao Chi
Lai Jiang
Xuancheng Zhou
Lexin Wang
Guanhu Yang
Honghao Luo
Xiaoli Liu
Ke Xu
Gang Tian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527428

574 views

Navigation group

Articles

Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers

Editorial: Investigating tumor immunotherapy responses in lung cancer using deep learning

Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease

Integrating omics data and machine learning techniques for precision detection of oral squamous cell carcinoma: evaluating single biomarkers

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis

A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy

Identification of SPP1+ macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics

Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor Immune Microenvironment) in distant tumors

Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma

Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study

Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports

Research on the influence of radiotherapy-related genes on immune infiltration, immunotherapy response and prognosis in melanoma based on multi-omics

Editorial: Immune cell exhaustion: new challenges and opportunities in cancer therapy